Skip to main content
. 2021 Jul 2;11:621834. doi: 10.3389/fonc.2021.621834

Figure 7.

Figure 7

Minimally invasive, comprehensive treatment for metastatic lymph nodes. (A) S4 HCC with metastatic lymph nodes in the portal vena cava space that were pathologically confirmed as HCC. The AFP level was 439 ng/mL before treatment; (B) Two weeks after TACE treatment, subsequent RFA was performed; (C) RFA ablation of hepatic portal metastatic lymph nodes; (D) Lymph nodes were basically inactivated, and 125I particles were implanted in the remaining portion; (E) Metastatic lymph nodes were completely necrotic, and the AFP level decreased to 14 ng/mL; (F) After adjuvant CIK treatment, the metastatic lymph nodes were completely inactivated, and AFP was further reduced to 2 ng/mL. The patient is still alive 10 years after treatment.